| 标题 |
A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:European Journal of Cancer 作者:Franck Morschhauser; Olivier Fitoussi; Corinne Haïoun; Catherine Thiéblemont; Hang Quach; et al 出版日期:2013-05-31 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)